MOCHIDA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,290 JPY | 0.00% |
|
+5.62% | +0.61% |
| Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Chart calendar Mochida Pharmaceutical Co., Ltd.
73db688ce0d6edb9f55136d.1tgV4z5eeML3zvYViicZxVft8E3EHWoFZfjicIiQD3Q.lPVE0wsOEIunoYIt2n9pshnf3XWVSVJ1KJ6JHPjeeRqYmSexURwC9oGbkQ~05edf358101a178559ac14c471eb8b6c
Upcoming events on Mochida Pharmaceutical Co., Ltd.
Past events on Mochida Pharmaceutical Co., Ltd.
| 2024-06-26 09:00 pm | Shareholders Meeting |
| 2024-05-12 | Q4 2023 Earnings Release |
| 2024-03-27 | Final dividend |
| 2024-02-04 | Q3 2023 Earnings Release |
| 2023-11-01 | Q2 2023 Earnings Release |
| 2023-09-27 | Détachement de for dividende intermédiaire |
| 2023-08-03 | Q1 2023 Earnings Release |
| 2023-06-28 09:00 pm | Shareholders Meeting |
| 2023-05-14 | Q4 2022 Earnings Release |
| 2023-03-29 | Détachement de for final dividend |
| 2023-02-05 | Q3 2022 Earnings Release |
| 2022-11-03 | Interim 2022 Earnings Release |
| 2022-09-28 | Détachement de for dividende intermédiaire |
| 2022-07-31 | Q1 2022 Earnings Release |
| 2022-06-28 09:00 pm | Annual General Meeting |
| 2022-05-12 | FY 2021 Earnings Release |
| 2022-03-29 | Détachement de for final dividend |
| 2022-02-03 | Q3 2022 Earnings Release |
| 2021-11-04 | Interim 2021 Earnings Release |
| 2021-09-28 | Détachement de for dividende intermédiaire |
Past dividends on Mochida Pharmaceutical Co., Ltd.
| 2024-03-27 | Final Payment 40 JPY |
| 2023-09-27 | Interim Payment 40 JPY |
| 2023-03-29 | Final Payment 40 JPY |
| 2022-09-28 | Interim Payment 40 JPY |
| 2022-03-29 | Final Payment 50 JPY |
| 2021-09-28 | Interim Payment 40 JPY |
| 2021-03-29 | Final Payment 50 JPY |
| 2020-09-28 | Interim Payment 40 JPY |
| 2020-03-29 | Final Payment 40 JPY |
| 2019-09-26 | Interim Payment 40 JPY |
Annual results
| Fiscal Period | Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 101 799 101 700 0.1% | 102 995 102 500 0.48% | 110 179 109 500 0.62% | 103 261 106 500 -3.04% | 102 885 102 000 0.87% | 106 000 |
|
EBITDA Million JPY | Released Forecast Spread | 11 538 11 400 1.21% | 14 745 13 200 11.7% | 17 081 15 700 8.8% | 11 179 12 100 -7.61% | 8 610 8 300 3.73% | 10 100 |
|
EBIT Million JPY | Released Forecast Spread | 8 807 8 700 1.23% | 12 003 10 500 14.31% | 14 392 13 000 10.71% | 8 507 9 500 -10.45% | 5 802 5 500 5.49% | 7 500 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 6 273 6 000 4.55% | 11 900 10 700 11.21% | 14 591 13 200 10.54% | 9 044 9 750 -7.24% | 6 160 5 600 10% | 7 600 |
|
Net income Million JPY | Released Forecast Spread | 4 598 4 500 2.18% | 8 587 7 700 11.52% | 10 569 9 500 11.25% | 6 649 7 100 -6.35% | 4 547 4 400 3.34% | 5 900 |
|
EPS JPY | Released Forecast Spread | 118 115 1.87% | 222 200 11.15% | 277 250 11% | 179 193 -7.1% | 127 124 2.34% | 166 |
| Announcement Date | 15/05/20 | 14/05/21 | 13/05/22 | 15/05/23 | 13/05/24 | - |
Quarterly results
| Fiscal Period | March | 2021 S1 | 2022 S1 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 51 623 52 800 -2.23% | 54 009 50 900 6.11% | 25 365 24 686 2.75% | 27 692 28 400 -2.49% | 25 508 25 508 0% | 53 200 53 200 0% | 28 194 28 900 -2.44% | 21 867 25 106 -12.9% | 24 747 25 700 -3.71% | 24 729 25 053 -1.29% | 49 476 49 800 -0.65% | 28 742 27 200 5.67% | 24 667 23 782 3.72% |
|
EBIT Million JPY | Released Forecast Spread | 7 229 6 400 12.95% | 6 131 5 600 9.48% | 1 347 -45,0 3093.33% | 4 265 3 400 25.44% | 1 014 1 535 -33.94% | 5 279 5 800 -8.98% | 5 077 4 521 12.3% | -1 849 -856 -116% | 2 515 2 600 -3.27% | 1 437 185 676.76% | 3 952 2 700 46.37% | 1 839 4 300 -57.23% | 11,0 -291 103.78% |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 7 353 | 6 793 | 4 414 | 5 412 | 5 195 | 2 572 | 4 049 | 1 994 | |||||
|
Net income Million JPY | Released Forecast Spread | 5 411 4 700 15.13% | 4 916 4 176 17.72% | 389 -680 157.21% | 3 155 2 628 20.05% | 768 1 225 -37.31% | 3 923 4 380 -10.43% | 4 158 3 450 20.52% | -1 432 -981 -45.97% | 1 688 1 944 -13.17% | 1 150 328 250.61% | 2 838 2 016 40.77% | 1 606 3 168 -49.31% | 103 -44,0 334.09% |
|
EPS JPY | Released Forecast Spread | 140 | 128 | 84,0 | 105 | 112 | 46,2 | 78,4 | 45,1 | |||||
| Announcement Date | 02/11/20 | 05/11/21 | 13/05/22 | 01/08/22 | 04/11/22 | 04/11/22 | 06/02/23 | 15/05/23 | 04/08/23 | 02/11/23 | 02/11/23 | 05/02/24 | 13/05/24 |
| 2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
| 2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
| 2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
| 2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
| 2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
| 2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Mochida Pharmaceutical Co., Ltd.
| 2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4534 Stock
- Calendar Mochida Pharmaceutical Co., Ltd.
